Cadence Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2013 Financial Results
3/3/2014 6:09:25 AM
SAN DIEGO, Feb. 28, 2014 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and twelve months ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by